Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ulrike Protzer

Showing results (21-30 of 308) with videos related to

Pageof 31
Sort By:
JHEP Reports : Innovation in Hepatology|April 8, 2026
Elebsiran and pegylated-IFNα: Progress toward a functional cure for chronic hepatitis BSara Battistella, Ulrike Protzer, Xavier Forns
Digestive Diseases (Basel, Switzerland)|June 26, 2013
Direct effects of hepatitis B virus-encoded proteins and chronic infection in liver cancer developmentMarc Ringelhan, Mathias Heikenwalder, Ulrike Protzer
Journal of Virology|August 4, 2019
Revisiting Hepatitis B Virus: Challenges of Curative TherapiesJianming Hu, Ulrike Protzer, Aleem Siddiqui
Current Opinion in Virology|April 29, 2017
Therapeutic vaccination for chronic hepatitis BAnna D Kosinska, Tanja Bauer, Ulrike Protzer
World Journal of Gastroenterology|June 20, 2020
Innate immune recognition and modulation in hepatitis D virus infectionStephanie Jung, Sebastian Maximilian Altstetter, Ulrike Protzer
Transplantation|December 13, 2016
Immune Reconstitution After HCV Clearance With Direct Antiviral Agents: Potential Consequences for Patients With HCC?Jens M Werner, Akinbami Adenugba, Ulrike Protzer
Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences|September 13, 2017
Viral hepatitis and liver cancerMarc Ringelhan, Jane A McKeating, Ulrike Protzer
Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences|November 22, 2017
Correction to 'Viral hepatitis and liver cancer'Marc Ringelhan, Jane A McKeating, Ulrike Protzer
Oncotarget|August 3, 2013
Adoptive T-cell therapy to treat liver cancer: is the liver microenvironment key?Gerald Willimsky, Ulrike Protzer, Percy Knolle, et al.
The Journal of Pathology|September 9, 2014
The direct and indirect roles of HBV in liver cancer: prospective markers for HCC screening and potential therapeutic targetsMarc Ringelhan, Tracy O'Connor, Ulrike Protzer, et al.
Pageof 31

Showing results (21-30 of 308) with videos related to

Sort By:
Pageof 31
JHEP Reports : Innovation in Hepatology|April 8, 2026
Elebsiran and pegylated-IFNα: Progress toward a functional cure for chronic hepatitis BSara Battistella, Ulrike Protzer, Xavier Forns
Digestive Diseases (Basel, Switzerland)|June 26, 2013
Direct effects of hepatitis B virus-encoded proteins and chronic infection in liver cancer developmentMarc Ringelhan, Mathias Heikenwalder, Ulrike Protzer
Journal of Virology|August 4, 2019
Revisiting Hepatitis B Virus: Challenges of Curative TherapiesJianming Hu, Ulrike Protzer, Aleem Siddiqui
Current Opinion in Virology|April 29, 2017
Therapeutic vaccination for chronic hepatitis BAnna D Kosinska, Tanja Bauer, Ulrike Protzer
World Journal of Gastroenterology|June 20, 2020
Innate immune recognition and modulation in hepatitis D virus infectionStephanie Jung, Sebastian Maximilian Altstetter, Ulrike Protzer
Transplantation|December 13, 2016
Immune Reconstitution After HCV Clearance With Direct Antiviral Agents: Potential Consequences for Patients With HCC?Jens M Werner, Akinbami Adenugba, Ulrike Protzer
Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences|September 13, 2017
Viral hepatitis and liver cancerMarc Ringelhan, Jane A McKeating, Ulrike Protzer
Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences|November 22, 2017
Correction to 'Viral hepatitis and liver cancer'Marc Ringelhan, Jane A McKeating, Ulrike Protzer
Oncotarget|August 3, 2013
Adoptive T-cell therapy to treat liver cancer: is the liver microenvironment key?Gerald Willimsky, Ulrike Protzer, Percy Knolle, et al.
The Journal of Pathology|September 9, 2014
The direct and indirect roles of HBV in liver cancer: prospective markers for HCC screening and potential therapeutic targetsMarc Ringelhan, Tracy O'Connor, Ulrike Protzer, et al.
Pageof 31